Original Research
This institution transitioned the leadership of its survivorship program to a nurse navigator and achieved excellent results
Chelsea Bostelman, MSN, APRN, AGCNS-BC, OCN, Teresa Parent, RN, BSN, OCN, Shannon Elpers, BSN, RN, Chelsea Passwater, DNP, APRN, AGCNS-BC, OCN
To describe types of molecular testing and discuss considerations for their application in NSCLC to support the role of the nurse navigator in facilitating efficient molecular testing.
Young women with breast cancer, as well as women with
metastatic breast cancer, have unique needs as part of their
treatment and survivorship plan. Researchers report on the
needs of the oncology nurse navigators who serve these
special populations.
How can we strengthen support for both navigators and navigation systems? Researchers from the Cancer Navigation and Survivorship Network reveal the findings from their recent survey.
A team of navigators studied a program designed to improve surgical care and outcomes for older adults through a multidisciplinary approach to early intervention and prevention strategies.
Connecting patients with a navigator upon initial diagnosis supports seamless coordination of care.
African American culture, the importance of the patient voice, and story sharing are just some of the themes that emerged from a study to understand the work of African American breast cancer advocates.
CLL’s unique properties may lead to providers and patients conceptualizing the prognosis differently. These findings present new information about the needs of people with CLL, with potentially transferable implications for people with other chronic illnesses. Information should be shared with providers about how to discuss a CLL prognosis sensitively.
More than 1.6 million people are diagnosed with cancer each year. Despite the different treatment options available for cancer, many individuals refuse treatment for various reasons. However, little is known about the cumulative group of individuals who refuse treatment.
Fox Chase Cancer Center (FCCC) in collaboration with AONN+ conducted a pilot study to evaluate patient efficacy, provider feedback, and implementation of CAPE Lung using an implementation science framework in diverse cancer settings.